Vimarsana
Biggest News Aggregation in the World

Motti Farbstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Motti Farbstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Motti Farbstein Today - Breaking & Trending Today

Join Can-Fite's Exclusive Live Investor Webinar and Q&A Session on June 6 - Vimarsana News

Join Can-Fite's Exclusive Live Investor Webinar and Q&A Session on June 6

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, is pleased to invite investors to a...

Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON June 26, 2024 To the shareholders of Can-Fite BioPharma Ltd.: ...

Can Fite BioPharma : Immediate Report of Meeting - Vimarsana News

Can Fite BioPharma : Immediate Report of Meeting

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of...

Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602 - Vimarsana News

Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602

Patent has already been issued in other major markets including the U.S. ...

Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal - Vimarsana News

Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article...